Article
The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice.
Brain & development - 1 Apr 2013
Luan Zhuo, Li Linjing, Higaki Katsumi, Nanba Eiji, Suzuki Yoshiyuki, Ohno Kousaku
Abstract excerpt
Gaucher disease (GD), caused by a defect of acid β-glucosidase (β-Glu), is one of the most common sphingolipidoses. Recently, ambroxol, an FDA-approved drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified as a chemical chaperone for GD. In the present study, we investigated the chaperone activity and toxicity of ambroxol on both cultured GD patient cells and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
